Intervention: vasodilator

Bellmann-Strobl

Germany
|
2023-2025
  • Adults (18-64 years)
  • General population
  • Outpatient clinic
  • Community
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • vasodilator
  • Vericiguat